ISPOR Italy - Rome Chapter

Name

ISPOR Italy - Rome Chapter

Legal name

ISPOR Italy - Rome Chapter

Website

https://isporitaly.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Professional Scientific Association Services

NAICS

Professional Organizations (813920), Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro industry

PRIMARYHLAJAKAN

Global Health Research, Evidence & Technical Assistance Organizations

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

SECONDARYEDAHAGAM

Global Health Institutes & Programs

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

Keywords

• Health economics research
• Pharmacoeconomics education
• Outcomes research training
• Health technology assessment
• Scientific association membership

Headquarters

HQ city

Rome

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Marketing or Sales, Personnel, Others

Revenue model

1. Membership fees: The association generates revenue through annual membership fees. Standard membership: €50.00 per year, €80.00 biennial, €100.00 triennial. Young professionals under 35 receive free membership. These fees fund the association's activities including conferences, working groups, publications, and training programs.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

ISPOR Italy - Rome Chapter is a non-profit scientific association that promotes pharmacoeconomics and health outcomes research in Italy. It delivers this mission through annual national congresses, GIRF youth congresses, specialized training courses (Budget Impact, Economic Evaluation, Summer/Winter School), thematic Working Groups, and the publication of Good Practices, guidelines, and newsletters for healthcare professionals, institutions, and industry members.

Product overview

ISPOR Italy - Rome Chapter is a single unified association offering a portfolio of scientific and educational services focused on Health Economics and Outcomes Research (HEOR). The organization's offerings include national congresses (ISPOR National Convegni), the GIRF youth group initiative for young professionals, training courses (Summer School, Winter School, Budget Impact courses, Economic Evaluation courses), working groups (HE&OR, Evidence Synthesis, Market Access & Health Policy), newsletters, and published documents including Good Practices (Buone Pratiche) reports. These services are designed to advance evidence-based healthcare decision-making in Italy's National Health System.

Differentiator

Problem solved

Functional benefit

Brands

• GIRF (Gruppo ISPOR Roma for Future): Youth network under ISPOR Italy Rome Chapter focused on Health Economics and Outcome Research (HEOR) for professionals under 35

Products and services

• ISPOR Italy - Rome Chapter Membership Paid annual, biennial, or triennial membership subscription (€50/year, €80 biennial, €100 triennial) for healthcare professionals, researchers, and institutional stakeholders; free for individuals under 35. Members access national congresses, working groups, training programs, newsletters, and member-only scientific documents.
• HEOR Training Courses (Budget Impact, Economic Evaluation, Summer School, Winter School ISPOR/SIF) Standalone paid professional training courses for healthcare professionals, economists, and industry practitioners on Budget Impact analysis, Economic Evaluation, and HEOR methodologies, delivered in partnership with SIF (Winter School).
• GIRF (Gruppo ISPOR Roma for Future) Youth Professional Network Named network program for HEOR professionals under 35, providing career development, networking, training, and research collaboration through the annual GIRF National Congress (4th edition in Florence, June-July 2025; 5th edition in Verona, June 2026) and a Coordinating Committee (2025-2027 cohort).
• Working Groups (HE&OR, Evidence Synthesis, Market Access & Health Policy) Structured working groups that bring together members to develop good-practice documents, consensus papers, and guidelines on pharmacoeconomics, evidence synthesis, and market access for the Italian healthcare context.

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• RegeneroncoreOthers · 1 January 2026Regeneron is listed as a Premium Supporting Member (socio sostenitore premium 2026) of ISPOR Italy Rome Chapter. As a supporting member, Regeneron provides financial sponsorship for the association's activities and congresses.
• Eli Lilly ItaliacoreOthers · 1 January 2026Eli Lilly Italia appears as a supporting member (socio sostenitore 2026) of ISPOR Italy Rome Chapter, providing sponsorship for the association's activities.
• Gilead SciencescoreOthers · 1 January 2026Gilead Sciences is listed as a supporting member (socio sostenitore 2026) of ISPOR Italy Rome Chapter.
• AGENAS (Agenzia Nazionale per i Servizi Sanitari Regionali)coreStrategic or Co-development PartnerISPOR Italy Rome Chapter is registered in the AGENAS Stakeholder Network (Rete dei Portatori di Interesse Agenas), confirmed in the Board meeting of November 25, 2024. This partnership facilitates engagement with national health technology assessment initiatives.
• EdraminorOthersCollaboration with Edra for the 10-year anniversary event of ISPOR Italy Rome Chapter, mentioned in the Board meeting of November 25, 2024.
• EFPIA (European Federation of Pharmaceutical Industries and Associations)minorStrategic or Co-development PartnerCollaboration with EFPIA representative Matteo Scarabelli on initiatives discussed in Board meetings in 2023.
• SIF (Società Italiana di Farmacologia)coreStrategic or Co-development PartnerJoint Winter School program with SIF (Società Italiana di Farmacologia), announced in newsletters for 2025. The ISPOR/SIF Winter School provides specialized training in pharmacology and health economics.
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research)coreStrategic or Co-development PartnerISPOR Italy Rome Chapter is an official affiliated chapter of ISPOR, the international society founded in 1995. The chapter connects Italian professionals to ISPOR's global activities, conferences (including ISPOR Europe), and initiatives.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Others

• AIFA (Agenzia Italiana del Farmaco): Italian medicines regulator; sets the pricing, reimbursement and HTA framework that drives the chapter's programming and member interests. A governing/adjacent institution rather than a competing society.
• AGENAS (Agenzia Nazionale per i Servizi Sanitari Regionali): Italy's national agency for regional health services; the chapter is a registered stakeholder in AGENAS's network. Not a competing society, but an institutional enabler of the chapter's HTA policy access and a key adjacency for the Italian HEOR ecosystem.

Emerging players

• EHMA (European Health Management Association): European association focused on health management, policy, and innovation; shares an audience of healthcare decision-makers, policymakers, and managers across Europe and overlaps thematically with the chapter's market-access and health-policy working group.

Direct peers

• AIES (Associazione Italiana di Economia Sanitaria): Italian scientific association for health economics; both organizations serve Italian clinicians, economists and health-policy decision-makers and address overlapping HEOR, HTA, and market-access topics, competing for the same domestic membership and sponsor pool.
• SIF (Società Italiana di Farmacologia): Italian pharmacology society that co-runs the ISPOR/SIF Winter School with the chapter and shares members across pharmacology and HEOR; both convene Italian scientific events, training courses, and working groups in drug evaluation and access.
• SIHTA (Società Italiana di Health Technology Assessment): Italian HTA-focused scientific society with overlapping scope in health technology assessment, economic evaluation, and policy engagement; both compete for the same Italian HTA professionals, payers, and pharma market-access sponsors.
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research): Parent global scientific society in HEOR; the Italy-Rome Chapter is a direct affiliate of ISPOR and shares its mission, conference formats (ISPOR Europe, ISPOR conferences), good-practice reports, and training content, serving overlapping researcher and decision-maker audiences.

Broad incumbents

• ISPOR Europe (regional conferences and chapters): ISPOR's European regional structure (including ISPOR Europe conferences and other European chapters) addresses the same HEOR audience at a broader geographic scale; functions as a larger incumbent that competes for sponsor mind-share and member attention.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ispor-italy-rome-chapter

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ISPOR Italy - Rome Chapter